Not at all. It's probably related to the Biocell deal that was closed just prior to the end of the quarter. They had the same problem the last time due to the Stellacure numbers. I'm interested for sure. Just don't expect enough to move the share price unless there is some kind of surprise that I really don't expect. Acquisition news is what will move us up IMO.
Don't worry about the mule going blind just load the wagon.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.